Clinical trial · Interventional
NuGa (Nutrition for Gastric Cancer Patients)
A Pilot Study to Evaluate the Feasibility and Efficacy of Digital Health Technology for Postoperative Care With Gastrectomy-Treated Patients in Gastric Cancer
NCT04800991CI-TRIAL-00054563completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this pilot study is to evaluate the feasibility and efficacy of Rhexium Onco Nutrition, HDT-202 for post-operative care in patients who have undergone gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Rhexium Onco Nutrition | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Rhexium Onco Nutrition(HDT-202)
- description
- "subject mobile application" and "Investigator web portal" with no invasive action on the human body
- interventionNames
- Device: Rhexium Onco Nutrition
Primary outcomes (4)
- measure
- Score of each domain of the 'feasibility assessment of the investigational device (application)' questionnaire for subjects
- timeFrame
- Week 2 (Visit 2)
- description
- higher scores mean a better outcome
- measure
- Score of each domain of the 'feasibility assessment of the investigational device (application)' questionnaire for subjects
- timeFrame
- Week 6 (Visit 3),
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patient who voluntarily signs the informed consent form for this study 2. Age of ≥19 years old 3. Patient who has undergone therapeutic gastrectomy after a diagnosis of gastric cancer 4. Able to eat food orally after gastrectomy 5. Patient who possesses an Android OS based mobile device and is capable of using the investigational device. Exclusion Criteria: 1. Other cancer or metastasis documented within 5 years prior to screening 2. Ongoing or planned enteral tube feeding or total parenteral nutrition 3. Other clinically significant medical or psychiatric findings based on which the individual is considered by the investigator to be ineligible 4. Individual who possesses a mobile device on which the application is unable to be installed and/or run normally for technical reasons 5. Individual who, in the opinion of the investigator, has difficulty understanding how to use the investigational device or is unlikely to comply with other study procedures
References
Publications (1)
- DERIVEDPark JH, Lee HJ, Kim J, Cho YS, Lee S, Park S, Choe H, Song E, Kim Y, Kong SH, Park DJ, Nam BH, Yang HK. Development and Feasibility Assessment of Mobile Application-Based Digital Therapeutics for Postoperative Supportive Care in Gastric Cancer Patients Following Gastrectomy. J Gastric Cancer. 2024 Oct;24(4):420-435. doi: 10.5230/jgc.2024.24.e37. PMID 39375057